4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-18-004643
Director sold 33,292 shares at an average $60.44 ($2,012,209)
- Director acquired 33,292 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BESHAR LUKE M · Director
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-11-19 | Exercise or conversion : show line 1 in the form | +2,604 | $49.45 | $128,768 | 2,604 | D |
| 2018-11-19 | Exercise or conversion : show line 2 in the form | +6,250 | $18.85 | $117,813 | 8,854 | D |
| 2018-11-19 | Exercise or conversion : show line 3 in the form | +3,262 | $12.74 | $41,558 | 12,116 | D |
| 2018-11-19 | Sale : show line 4 in the form | −10,916 | $60.26 | $657,798 | 1,200 | D |
| 2018-11-19 | Sale : show line 5 in the form | −600 | $62.81 | $37,686 | 600 | D |
| 2018-11-19 | Sale : show line 6 in the form | −600 | $63.53 | $38,118 | 0 | D |
| 2018-11-20 | Exercise or conversion : show line 7 in the form | +4,688 | $22.00 | $103,136 | 4,688 | D |
| 2018-11-20 | Exercise or conversion : show line 8 in the form | +2,988 | $12.74 | $38,067 | 7,676 | D |
| 2018-11-20 | Exercise or conversion : show line 9 in the form | +13,500 | $3.76 | $50,760 | 21,176 | D |
| 2018-11-20 | Sale : show line 10 in the form | −21,176 | $60.38 | $1,278,607 | 0 | D |
| Open-market sales · 33,292 sh · avg $60.44 · $2,012,209 | ||||||
Table II: Derivative
6 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-11-19 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −2,604 | $49.45 | 2028-05-25 | 2,604 | 9,896 | D |
| 2018-11-19 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −6,250 | $18.85 | 2027-05-24 | 6,250 | 6,250 | D |
| 2018-11-19 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −3,262 | $12.74 | 2026-06-01 | 3,262 | 9,238 | D |
| 2018-11-20 | Exercise or conversion : show line 14 in the form Stock Option (Right to Buy) | −4,688 | $22.00 | 2025-09-16 | 4,688 | 4,687 | D |
| 2018-11-20 | Exercise or conversion : show line 15 in the form Stock Option (Right to Buy) | −2,988 | $12.74 | 2026-06-01 | 2,988 | 6,250 | D |
| 2018-11-20 | Exercise or conversion : show line 16 in the form Stock Option (Right to Buy) | −13,500 | $3.76 | 2025-05-18 | 13,500 | 66,500 | D |
Loading xslF345X03/primarydocument.xml…